Glucose-incretin interaction revisited

Endocrine Journal

Volumn 58, Issue 7, 2011, Pages 519-525

  Ishii, Hiroaki ^a   Sato, Yoshihiko ^a   Takei, Masahiro ^a   Nishio, Shinichi ^a   Komatsu, Mitsuhisa ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ATP sensitive K + channel; cAMP; Glucose; Incretin; Insulin secretion

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLINIDE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; GLUCOSE; INCRETIN; INSULIN; SULFONYLUREA; UNCLASSIFIED DRUG;

EXOCYTOSIS; HUMAN; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MEMBRANE DEPOLARIZATION; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; REVIEW; SIGNAL TRANSDUCTION; STIMULUS SECRETION COUPLING;

CALCIUM CHANNELS, L-TYPE; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INCRETINS; INSULIN; INSULIN-SECRETING CELLS; KATP CHANNELS; SIGNAL TRANSDUCTION;

EID: 79960995890     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0064     Document Type: Review

References (41)

1. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH (1991) A two-step model for development of non-insulin-dependent diabetes. Am J Med 90(2): 229-235.
2. Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, Kuzuya N, Takaku F, Kosaka K (1984) Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26(1): 44-49.
3. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104(6): 787-794.
4. Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, Nagata I, Tokuyama K (1992)Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41(12): 1540-1546.
5. Sato Y, Komatsu M, Katakura M, Ohfusa H, YamadaS, Yamauchi K,Hiramatsu K, Ichikawa K, Aizawa T, Hashizume K (2002) Diminution of early insulin response to glucose in subjects with normal but minimally elevated fasting plasma glucose. Evidence for early beta-cell dysfunction. Diabet Med 19(7): 566-571.
6. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J (1992) Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326(1): 22-29.
7. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Pettiti M, Natali A, Mari A, DeFronzo RA (2003) Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46(9): 1211-1219.
8. Goldfine AB, Bouche C, Parker RA, Kim C, Kerivan A, Soeldner JS, Martin BC, Warram JH, Kahn CR (2003) Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A 100(5): 2724-2729.
9. Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24(1): 89-94.
10. Defronzo RA. Banting Lecture (2009) From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4): 773-795.
11. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373(9682): 2215-2221.
12. Katakura M, Komatsu M, Sato Y, Hashizume K, Aizawa T (2004) Primacy of beta-cell dysfunction in the development of hyperglycemia: a study in the Japanese general population. Metabolism 53(7): 949-953.
13. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359(15): 1577-1589.
14. Aizawa T, Sato Y, Komatsu M (2002) Importance of nonionic signals for glucose-induced biphasic insulin secretion Diabetes 51 Suppl 1: S96-98.
15. Best L, Yates AP, Tomlinson S (1992) Stimulation of insulin secretion by glucose in the absence of diminished potassium (86Rb+) permeability. Biochem Pharmacol 43(11): 2483-2485.
16. + channels in mouse B cells. J Clin Invest 89(4): 1288-1295.
17. 2+ influx in rat pancreatic B-cell. Diabetes 41(4): 438-443.
18. + channels in mouse B cells. J Clin Invest 91(3): 871-880.
19. Asanuma N, Aizawa T, Sato Y, Schermerhorn T, Komatsu M, Sharp GW, Hashizume K (1997) Two signaling pathways, from the upper glycolytic flux and from the mitochondria, converge to potentiate insulin release. Endocrinology 138(2): 751-755.
20. 2+ in rat pancreatic islets. Proc Natl Acad Sci U S A 92(23): 10728-10732.
21. 2+: new insights into stimulus-secretion coupling. Diabetes 46(12): 1928-1938.
22. 2+-independent phenomenon. J Endocrinol 172(2): 345-354.
23. +-ATP channel-independent pathway of regulation of insulin secretion by glucose: in search of the underlying mechanism. Diabetes 47(11): 1713-1721.
24. 2+-independent pathways in stimulus-coupling to insulin secretion can be distinguished by their guanosine triphosphate requirements: studies on rat pancreatic islets. Endocrinology 139(3): 1172-1183.
25. Metz SA, Meredith M, Rabaglia ME, Kowluru A (1993) Small elevations of glucose concentration redirect and amplify the synthesis of guanosine 5'-triphosphate in rat islets. J Clin Invest 92(2): 872-882.
26. 2+. Diabetes 47(3): 352-357.
27. + channelindependent insulinotropic action of glucose. Diabetes 48(8): 1543-1549.
28. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE (1992) Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem 267(9): 5802-5810.
29. Yajima H, Komatsu M, Yamada S, Straub SG, Kaneko T, Sato Y, Yamauchi K, Hashizume K, Sharp GW, Aizawa T (2000) Cerulenin, an inhibitor of protein acylation, selectively attenuates nutrient stimulation of insulin release: a study in rat pancreatic islets. Diabetes 49(5): 712-717.
30. Yamada S, Komatsu M, Sato Y, Yamauchi K, Aizawa T, Kojima I (2003) Nutrient modulation of palmitoylated 24-kilodalton protein in rat pancreatic islets. Endocrinology 144(12): 5232-5241.
31. Huypens P, Pillai R, Sheinin T, Schaefer S, Huang M, Odegaard ML, Ronnebaum SM, Wettig SD, Joseph JW (2011) The dicarboxylate carrier plays a role in mitochondrial malate transport and in the regulation of glucose- stimulated insulin secretion from rat pancreatic beta cells. Diabetologia 54(1): 135-145.
32. Nakagawa Y, Nagasawa M, Yamada S, Hara A, Mogami H, Nikolaev VO, Lohse MJ, Shigemura N, Ninomia Y, Kojima I (2009) Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signaling systems and stimulates insulin secretion. PLoS One 4(4): e5106.
33. Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3: 153-165.
34. Ozaki N, Shibasaki T, Kashima Y, Miki T, Takahashi K, Ueno H, Sunaga Y, Yano H, Matsuura Y, Iwanaga T, Takai Y, Seino S (2000) cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2(11): 805-811.
35. Seino S, Shibasaki T (2005) PKA-dependent and PKAindependent pathways for cAMP-regulated exocytosis. Physiol Rev 85(4): 1303-1342.
36. Seino S, Takahashi H, Fujimoto W, Shibasaki T (2009) Roles of cAMP signalling in insulin granule exocytosis. Diabetes Obes Metab 11: 180-188.
37. + channel-independent pathway of glucose signaling in rat pancreatic islets. Diabetes 48(5): 1006-1012.
38. Yamada S, Komatsu M, Sato Y, Yamauchi K, Kojima I, Aizawa T, Hashizume K (2002) Time-dependent stimulation of insulin exocytosis by 3',5'-cyclic adenosine monophosphate in the rat islet beta-cell. Endocrinology 143(11): 4203-4209.
39. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC (1998) UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 15(4): 297-303.
40. Zhang CL, Katoh M, Shibasaki T, Minami K, Sunaga Y, Takahashi H, Yokoi N, Iwasaki M, Miki T, Seino S (2009) The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 325(5940): 607-610.
41. Herbst KJ, Coltharp C, Amzel LM, Zhang J (2011) Direct activation of Epac by sulfonylurea is isoform selective. Chem Biol 18(2): 243-251.